The outputs are the leadership of the CDC. That
The dismissal of the director of the US disease control and prevention centers. And the resignation of several leaders of the high profile agency pose immediate challenges for the operations of the main public health agency of the Nation, experts said.
It could take “several months” to identify and confirm a replacement for the director of the CDC Susan Monaz, who was fired on Wednesday after less than a month at work, said Dr. Georges Benjamin, director of the American Public Health Association. And it could take more time to occupy at least four key unemployment positions that supervise the shoots of diseases, vaccines and public health data.
“The entire command chain has just been interrupted,” Benjamin told News. “It’s like getting rid of their generals in the middle of a war.”
Health experts said that Americans could see immediate effects, from the confusion about the availability of COVID-19 vaccines to delayed responses to sprouts of infectious diseases, such as measles or diseases transmitted by food caused by germs such as E. coli or listeria.
“The average American should worry about their safety and health and if the information that comes out of health and human services is reliable or reliable,” said Dr. Anne Schuchat, a former main deputy director of the CDC, who left the agency in 2021.
This is what you need to know about sudden changes in CDC.
The Washington Post through Getty Images
What happened this week?
The White House on Wednesday expelled Monaz after apparent clashes between the director of the CDC and Health Secretary Robert F. Kennedy Jr. about changes in the nation’s vaccine policy.
The White House authorities said Monarrez was fired because he was not aligned with the agenda of President Donald Trump and refused to resign.
This action coincided with the resignation this week of at least four leaders of the CDC agency: Dr. Debra Houry, deputy director of the agency; Dr. Daniel Jernigan, leader of the agency’s work on emerging infectious diseases; Dr. Demetre Daskalakis, a superior officer of the vaccine; and Dr. Jennifer Layden, who directed public health data efforts.
What happens later?
Monarch was the first director of the CDC to demand the confirmation of the Senate under a law that entered into force in 2023. Replace it would require Trump to nomine a new director, who would later need to be considered and confirmed by the Senate. On Thursday, Republican Senator Bill Cassidy said that high -profile outputs “will require supervision” of the Senate Health, Labor, Labor and Pensions Committee, which presides.
Meanwhile, Jim O’Neill, a Kennedy advisor, was touched on Thursday to serve as an interim CDC director, according to an administration official who requested anonymity to discuss a change of personnel that has not been formally announced. O’Neill was serving as an deputy secretary of HHS.
Replace leaders in the other positions, including those who maintained the work for years, will be difficult, said Schuchat.
“The four people who resigned led important parts of the agency and had respect for the nation and the world,” he said.
Bloomberg through Getty Images
In an appearance in “News & Friends”, Kennedy refused to comment directly on the jolt of the CDC. But he said he is concerned about CDC officials who adhere to the vision of the administration of health policies.
“Therefore, we must observe the priorities of the agency, if there is really a deeply embedded discomfort, I would say, discomfort in the agency,” Kennedy said. “And we need a strong leadership that will enter there and that can execute in the broad ambitions of President Trump.”
How could the changes affect the average Americans?
Apparently, the clash in the CDC was triggered by the conflict about changes in politics regarding the recommendations for COVID-19 vaccines that could make an opportunity more complicated for people.
The food and medication administration approved the updated COVID-19 shots on Wednesday, but limited its use for many Americans, and eliminated one of the two vaccines available for young children. The new three manufacturers are approved for all older adults, but the FDA reduced their use for adults and children to those with high -risk health conditions, such as asthma or obesity.
The FDA approval is usually reviewed by a Vaccine Advisory Committee of the CDC, which makes recommendations for use. Monararez said he would not automatically sign the recommendations of the Committee, which was selected by Kennedy, according to Dr. Richard Besser, a former interim director of the CDC. (Besser is now president of the Robert Wood Johnson Foundation, which helps support the Department of Health and Sciences of News).
The changes have new barriers to access millions of Americans, who would have to demonstrate their risk, and others that may want the shooting but suddenly they no longer qualify. Vaccines were previously recommended to Americans 6 months or more.
“These decisions, taken without supporting evidence, reflect a worrying pattern on the part of the HHS to interfere with the relationship between patients and their medical care providers and limit access to vaccines: public health tools avoid saving lives and reducing costs,” said Michael Osterholm, a infectious disease researcher at the University of Minnesota.
In addition, the interruption in the CDC could endanger many local health services with the support and experience of the agency, said Schucho. That could mean tracking an outbreak of infectious disease over low heat, such as measles or food outbreaks transmitted by food.
“It’s the water you drink, lead in your pipes. Look around your community,” he said. “If people are fine and healthy, it is probably partly due to CDC.”
__
AP reporter Michelle Price contributed from Washington.
__
The Department of Health and Sciences of News receives support from the Department of Science Education of the Howard Hughes Medical Institute and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.